Please assess the completion status of the following clinical trial:

Trial Title: Split Cohort Trial Comparing IVF Outcomes After the Use of Testicular vs. Ejaculated Sperm for ICSI

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Willing to comply with all study procedures and be available for the duration of the study~* Failed at least one IVF cycle (i.e., no live birth)~* Elevated DNA fragmentation noted in ejaculated sperm (\>25% DFI according to the American Society of Reproductive Medicine guidelines)~* Couple electing single embryo transfer~* Couples electing comprehensive chromosome screening (CCS) of embryos~* At least 4 oocytes retrieved in IVF cycle in order to randomize~Exclusion Criteria:~* Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.~* Contraindication to IVF~* Clinical indication for preimplantation genetic diagnosis (PGD) (i.e., screening for single gene disorder, chromosomal translocation, or any other disorders requiring detailed embryo genetic analysis)~* Male partner with azoospermia (\<100,000 motile spermatozoa)~* Male partner with Y-chromosome microdeletion~* Male partner with any Karyotype other than 46,XY(normal male karyotype)~* Female partner history of hydrosalpinges or adnexal mass~* Female partner history of endometrial insufficiency (max endometrial thickness \< 7mm)~* Female partner BMI \< 35

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: None

Study Arms:
- elevated sperm DNA fragmentation (Type: None): Couples with male partners who will be undergoing a TESA procedure secondary to elevated DNA fragmentation (\>25% DFI) as part of their routine IVF treatment will have half of the women's eggs inseminated with ejaculated sperm and the other half with surgically obtained sperm via the ICSI procedure

Based on this trial design, predict the completion outcome and termination type (if applicable).